Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202...

FDA Recall #D-0098-2023 — Class II — December 20, 2022

Recall #D-0098-2023 Date: December 20, 2022 Classification: Class II Status: Terminated

Product Description

Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-0659-07, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, Repackaged NDC 70518-2404-00.

Reason for Recall

Failed Impurities/Degradation specifications

Recalling Firm

RemedyRepack Inc. — Indiana, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

132 Cards of 30 = 3960 Tablets

Distribution

Product was distributed to one account in PA.

Code Information

Lot #: J0599794-022322, exp. date 02/28/2023; J0621369-052622, exp. date 06/30/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls